Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yup...still acting terrible.
I assumed 50% gross margins. Do you have a better assumption?
The CEO is a former U.S. Naval Officer and Olympian!! He will get it done! Boom! I don't need to see anything else!
From what data/PRs do you get that 4M-5M in Q3? Those revenues should bring them to break even levels.
So is Christmas lol. Within 3 months?
Right now the revenues are small and it could take a while to build them up to significance ie $1M/month. I will stay out of the stock until this happens.
I almost bought on Monday. Good thing I did not!! Something just does not seem right to me. The stock is behaving poorly, that's all I need to know.
News not on OTC yet.
They need a website lol.
So they still need more financing to build out the business? When will all shares hit the market? Thanks
Is the Float now 1,000,000,000? Thanks in advance.
Anyone get any .0005's?
BSAV - How did you come up with forecasted revenues of $14M-$15M in 2014? Do you have any links to back it up? Thanks.
Merry Belated Christmas everyone!!
Consolidation over, time for the next run!!
Nice bounce!
When will they file their 9/30/13 financials? Anyone?
I wonder why you can't find the symbol MRIB on yahoo finance. Anyone?
Gentlemen - Start your engines!!!!
10 billion authorized!! I am staying away! Death sentence for a stock!
The market for Retinitis Pigmentosa is $1.5B. See link. Anyone else
have market data regarding this disease. Thanks.
http://www.gensight-biologics.com/retina-pigmentosa
With a prevalence of 200,000 patients in Europe and the USA, retinitis pigmentosa qualifies as an orphan disease. The goal of GenSight is to target the treatment of the most severe cases, patients having a VA < 20/400. There are an average of 14 000 patients that progress to this very severe situation each year in Europe and the USA. Taking as a conservative assumption that GenSight’s market share will correspond to only 50% of these patients, and with a similarly conservative assumption that the pricing of this one-shot gene therapy treatment will be at the level of 150K€/eye, retinitis pigmentosa represents a significant market opportunity, with potential peak sales exceeding USD 1500 million. If the treatment can then be extended to patients with AMD, it would expend the market size exceptionally.
Why does this stock have a market cap of $140M when the sales are just $300k in last quarter? Just because it is 3D?
I knew this would be a runner this week and into Chritmas day. This will be fun to watch!!!
I don't think it will get below .002. IMHO
2,2B shares O/S. What is the current Authorized Shares?
I have not been here in a while but can anyone comment on the 60,000,000 share puchase at .002 by Roos in mid Sept. per form 4? Is this an open market purchase or granted options? Thanks in advance.
Can you name the companies? Thanks!
Very well said! I agree completely, we think alike!
I assume BMAK is gone?
How do you know BMAK is almost done?
Lee - What's the next milestone for SVFC?
Diouble Bottom indeed!! Great time to add!!
I agree!! Double bottom off of .0035!
Sure seems like dilluter MM's are present the way it is trading.
Is BMAK there? Thanks in advance
Could they sell the mine and lease it back? Then they would get big revenues.
Where is the news that people were expecting?
What is the next PR/Event/Catalyst? Anyone? No guessing!